Mesoblast | MSB - Current Liabilities

Stock Price
2.05
Daily Change
-0.06 -2.84%
Monthly
-14.94%
Yearly
-1.44%
Q1 Forecast
2.07

Mesoblast reported $128.07M in Current Liabilities for its fiscal semester ending in December of 2025.





Current Liabilities Change Date
Avita Medical AUD 62.68M 77K Dec/2025
Clinuvel Pharmaceuticals AUD 25.21M 4.17M Jun/2024
Cochlear AUD 558.9M 43.4M Dec/2025
CSL USD 4.61B 207M Dec/2025
Pacific Edge NZD 7.22M 2.54M Dec/2025
Paradigm Biopharmaceuticals AUD 3.23M 2.15M Jun/2025
PYC Therapeutics AUD 11.01M 1.31M Dec/2025
Ramsay Health Care AUD 3.95B 514.2M Dec/2025
Sonic Healthcare AUD 2.23B 92.84M Dec/2024
Starpharma Holdings AUD 4.61M 614K Dec/2025
Telix Pharmaceuticals AUD 231.62M 66.96M Dec/2025